Opposition · USPTO

Opposition 91282389

OtherUSPTO

Opposition 91282389 at USPTO between Marvel Characters, Inc. and Xuegang Li, over the mark MARVENGER, filed Dec 19, 2022. Status in the office record: other.

Status
Other
Result
Other
Filed
Dec 19, 2022
Marks involved
24
Parties

Who is involved

The parties as named in the office record.

Opponent

Marvel Characters, Inc.

Company trademarks
Respondent

Xuegang Li

Timeline

How the case has moved

Dates from the USPTO record and the MARVENGER filing.

  1. MARVENGER filed

    Application 97163236 filed at the USPTO.
  2. Opposition filed

    Marvel Characters, Inc. started opposition 91282389 at USPTO against MARVENGER.
Marks

Marks involved

1 contested mark, 23 marks the challenger relies on.

MarkRoleApplicationOffice
MARVENGERContested97163236USPTO
MARVELRelied on72277923USPTO
THE AVENGERSRelied on72278015USPTO
MARVELRelied on74214396USPTO
MARVELRelied on74214398USPTO
MARVELRelied on74214399USPTO
AVENGERSRelied on75055468USPTO
MARVELRelied on77557580USPTO
MARVELRelied on77557582USPTO
AVENGERSRelied on78402866USPTO
AVENGERSRelied on85159382USPTO
MARVELRelied on85319257USPTO

+12 more marks in this case

API

Get this data via the API

Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.

  • GET/v1/proceedings/{id}

    Parties, dates, outcome and every mark in the case

  • GET/v1/proceedings?trademark_id={trademark_id}

    Every proceeding on a mark

GET /v1/proceedings/{id}
ID=prc_eb384967-17b0-463c-8cfd-7d955d98f12e
curl https://api.signa.so/v1/proceedings/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "prc_eb384967-17b0-463c-8cfd-7d955d98f12e",
  "object": "proceeding",
  "proceeding_type": "opposition",
  "proceeding_number": "91282389",
  "status": "other",
  "office_code": "US",
  "filed_date": "2022-12-19",
  "parties": [
    {
      "name": "Marvel Characters, Inc.",
      "role": "opponent"
    },
    {
      "name": "Xuegang Li",
      "role": "respondent"
    }
  ]
}